Results 171 to 180 of about 53,685 (285)

Efficacy and safety of extended-release carbidopa-levodopa (IPX203) versus immediate-release carbidopa-levodopa for Parkinson's disease: A systematic review. [PDF]

J Int Med Res
Attar A, Aljadani HH, Barwais KF, Alqsair AA, Alharbi FA, Alharith HM, Fallatah AA, Halabi MH, Hakami AY, Zagzoog N.   +9 more
europepmc   +1 more source

PINK1‐Associated Juvenile‐Onset Parkinsonism: Marked Phenotypic Variability and Limited Genotype–Phenotype Correlation

Movement Disorders, EarlyView.
Reza Maroofian, Ross Leng, Shilpan G. Patel, Hina Ojha, Heba Hosny, Maha Zaki, Miratul M.K. Muqit, Henry Houlden   +7 more
wiley   +1 more source

Neuropsychiatric and Cognitive Symptom Evolution over the First Decade of Biomarker‐Positive, Sporadic Parkinson's Disease

Movement Disorders, EarlyView.
Abstract Background Parkinson's disease (PD) is frequently accompanied by neuropsychiatric symptoms (NPS), including cognitive impairment, which often emerge early and co‐occur. Their long‐term evolution remains incompletely characterized, particularly in biomarker‐positive cohorts.
Izabelle Schoen, Jing Wang, Sharon X. Xie, Chelsea Caspell‐Garcia, Eugenia Mamikonyan, Melanie Stark, Nabila Dahodwala, Andrew D. Siderowf, Roseanne Dobkin, Michele K. York, Daniel Weintraub   +10 more
wiley   +1 more source

Clinical and Epidemiological Profile of Progressive Supranuclear Palsy in a Colombian Referral Center: A Retrospective Cohort Study. [PDF]

Neurol Res Int
Henao-Pérez M, López-Medina DC, Arboleda-Ramírez A, Barroso-Barrera Z, Londoño-Aristizábal JP.   +4 more
europepmc   +1 more source

Cerebellar Network Organization in Parkinson's Disease: Functional Connectivity across Motor and Cognitive Circuits

Movement Disorders, EarlyView.
Abstract Background The cerebellum is increasingly recognized as a key contributor to cognitive reserve and network organization in Parkinson's disease (PD). However, the relationship of cerebello‐cortical and cerebello‐basal ganglia connectivity with cognitive status and nigrostriatal integrity remains incompletely understood.
Chi‐Ying R. Lin, Thamires N.C. Magalhães, Shayla S. Yonce, Ihika Rampalli, Rory Mahabir, Jessica A. Bernard, and the Parkinson's Precision Medicine Initiative   +6 more
wiley   +1 more source

The Gut–Brain Axis in Parkinson's Disease: From Clinical Observation toward Mechanism‐Based Precision Medicine

Movement Disorders, EarlyView.
Abstract Gastrointestinal dysfunction is increasingly recognized as a core feature of Parkinson's disease (PD), affecting quality of life, nutrition, medication response, and potentially the earliest stages of pathogenesis. This perspective traces the evolution of the gut from a neglected source of non‐motor symptoms to a central component of ...
Filip Scheperjans, Per Borghammer, Ronald F. Pfeiffer, Silke Appel‐Cresswell, Ali Keshavarzian   +4 more
wiley   +1 more source

Levodopa-induced alterations in vertical center of mass and muscle synergy structure during Parkinsonian gait. [PDF]

Exp Brain Res
Aydın R, Oyama G, Shimoda S, Garcia AC, Kikuchi K, Hamada H, Shimazu T, Kameyama Y, Sato K, Kitahara E, Kamiyama D, Yamashita A, Fujiwara T, Hattori N, An Q.   +14 more
europepmc   +1 more source

Determinants of Cueing Responsiveness in Parkinson's Disease: Insights from the UNITE‐PD Study

Movement Disorders, EarlyView.
Abstract Background Cueing strategies are widely used to improve gait in Parkinson's disease (PD), but interindividual variability in cueing responsiveness remains poorly understood. Objectives The objective of the study was to identify determinants of internal and external cueing efficacy in persons with PD.
Cindel Albers, Laura Avanzino, Elsa de Lange, Alessandro Botta, Zoya Katzir, Matan Bouter, Veronica Romano, Moran Gilat, Bastiaan R. Bloem, Joris van der Cruijsen, Inbal Maidan, Alice Nieuwboer, Elisa Pelosin, Anouk Tosserams, Vivian Weerdesteyn, Anat Mirelman, Jorik Nonnekes   +16 more
wiley   +1 more source

Transcriptome‐Based Identification of ZZEF1 and ENTPD5 as Candidate Genes for Dystonia

Movement Disorders, EarlyView.
Alexandra Rudnik, Mirja Thomsen, Vicente A. Yépez, Ai Huey Tan, Frauke Hinrichs, Sebastian Loens, Shen‐Yang Lim, Yi Wen Tay, Thomas Musacchio, Sören Franzenburg, Tobias Bäumer, Marius Möller, Hauke Busch, Christine Klein, Norbert Brüggemann, Katja Lohmann   +15 more
wiley   +1 more source

Skin Seed Amplification Assay Differentiates Multiple System Atrophy from Parkinson's Disease

Movement Disorders, EarlyView.
Abstract Background Misdiagnoses of multiple system atrophy (MSA) and Parkinson's disease (PD) remain common. Objective The objective of the study was to develop a skin α‐synuclein seed amplification assay (αSyn‐SAA) for detecting pathological α‐synuclein and distinguishing MSA from PD.
Anastasia Kuzkina, Diego Rodriguez, Celine Panzer, Alain Ndayisaba, Antonia Kohl, Shreya Rai, Breelyn Gilbert, Bruno Hammerschlag, Karie Shen, Lisa Harder‐Rauschenberger, Olivia Laun, Julia Meehan, Sucika Perumalla, Elena Salabasidou, Kristie Jones, Dalina Ceku, Robert Blum, Susanne Knorr, Camelia M. Monoranu, Claudia Sommer, Jens Volkmann, Barbara K. Changizi, Kathrin Doppler, Vikram Khurana   +23 more
wiley   +1 more source